August 30, 2023
In a significant development for the cannabis industry, U.S. health officials have recommended easing restrictions on cannabis and reclassifying it as a Schedule III drug under the Controlled Substances Act. The move could open the door to more cohesive payments systems in the sector. Get the Full Story Complete the form to unlock this article […]
